XP22.31 deletion which carries an unknown prognosis, is characterized by skin conditions (itchyosis) from lack of Steroid Sulfatase, undescended testicles, seizures and learning/developmental issues.
XP22.31 deletion which carries an unknown prognosis, is characterized by skin conditions (itchyosis) from lack of Steroid Sulfatase, undescended testicles, seizures and learning/developmental issues.
Rare/unknown.
Undescended testicles, x-linked itchyosis
Name | Description |
---|---|
Seizures | Seizures |
(R) Developmental Delays | Development Delays vary |
Hello! I created this board in the hopes that there may be others out there that have children - or have themselves - been diagnosed with XP22.31 deletion syndrome. My son, who is 2.5 years old, was diagnosed with the deletion when he was about a month old. Despite seeing genetics at multiple hospitals - as well as being followed by many other doctors - there is not much known about his condition at all. Now that he's getting older, his delays are much more obvious and I want to help him as much as possible. He is currently seen by five specialists in early intervention a week, and is working still on walking, talking and eating solid foods. He has had four surgeries - one for pyloric stenosis (4 months) and three for undescended testicles, and has been diagnosed with nystagmus, FPIES and X-linked icthyosis. He also has sensory issues.
If you're out there, I'd love to compare notes on experiences, other symptoms and things that have helped!
CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, individuals and researchers to help in the advancement of research in over 7,000 rare diseases. The registry is free for patients to enroll and researchers to access.
Enrolling is easy.
After these steps, the enrollment process is complete. All other questions are voluntary. However, these questions are important to patients and their families to create awareness as well as to researchers to study rare diseases. This is why we ask our participants to update their information annually or anytime changes to their information occur.
Researchers can contact CoRDS to determine if the registry contains participants with the rare disease they are researching. If the researcher determines there is a sufficient number of participants or data on the rare disease of interest within the registry, the researcher can apply for access. Upon approval from the CoRDS Scientific Advisory Board, CoRDS staff will reach out to participants on behalf of the researcher. It is then up to the participant to determine if they would like to join the study.
Visit sanfordresearch.org/CoRDS to enroll.
Start your own! With a worldwide network of 8,000 users, you won't be the only member of your community for long.
Visit our Frequently Asked Questions page to find the answers to some of the most commonly asked questions.
Created by AlisonCizowski | Last updated 19 Feb 2019, 10:01 PM
Join Rareshare to meet other people that have been touched by rare diseases. Learn, engage, and grow with our communities.
FIND YOUR COMMUNITYOur rare disease resources include e-books and podcasts
Community leaders are active users that have been touched by the rare disease that they are a part of. Not only are they there to help facilitate conversations and provide new information that is relevant for the group, but they are there for you and to let you know you have a support system on Rareshare.